Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS INC.GBS · Entity 8088 | Director | October 10, 2022 | October 12, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTELLIGENT BIO SOLUTIONS INC.
Report date October 10, 2022 · Filed October 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
After 2022-10-10 transaction · row 1
1 source rowRow 1 · 2022-10-10 · Grant · Acquired 15,000 · Balance 15,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2022 Filed Oct 12, 2022 10:05 UTC | INTELLIGENT BIO SOLUTIONS INC. GBS · Entity 8088 | GrantCommon Stock, par value $0.01 per share | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-028191 · ownership.xml · nonDerivative · entry 1 Margelis George · CIK 0001830110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.